Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic portal systemic encephalopathy: update 1987.

Literature DB >> 3311906

Chronic portal systemic encephalopathy: update 1987.

S Sherlock¹.

Abstract

Entities: Disease

Mesh：

Substances：
Amino Acids
Lactulose

Year: 1987 PMID： 3311906 PMCID： PMC1433147 DOI： 10.1136/gut.28.8.1043

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

28 in total

1. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy.

Authors: J H James; V Ziparo; B Jeppsson; J E Fischer
Journal: Lancet Date: 1979-10-13 Impact factor: 79.321

2. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.

Authors: N J Greenberger; J Carley; S Schenker; I Bettinger; C Stamnes; P Beyer
Journal: Am J Dig Dis Date: 1977-10

3. Treatment of chronic portal-systemic encephalopathy with lactulose.

Authors: J Bircher; J Müller; P Guggenheim; U P Haemmerli
Journal: Lancet Date: 1966-04-23 Impact factor: 79.321

4. Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts.

Authors: S S Hanna; R S Smith; J M Henderson; W J Millikan; W D Warren
Journal: Am J Surg Date: 1981-08 Impact factor: 2.565

5. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors: H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal: Dig Dis Sci Date: 1981-07 Impact factor: 3.199

6. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease.

Authors: M Y Morgan; J P Milsom; S Sherlock
Journal: Gut Date: 1978-11 Impact factor: 23.059

7. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.

Authors: M Uribe; M A Márquez; G García-Ramos; V Escobedo; H Murillo; L Guevara; R Lisker
Journal: Dig Dis Sci Date: 1980-12 Impact factor: 3.199

8. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.

Authors: M Y Morgan; A W Jakobovits; I M James; S Sherlock
Journal: Gastroenterology Date: 1980-04 Impact factor: 22.682

9. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.

Authors: M Y Morgan; K E Hawley; D Stambuk
Journal: J Hepatol Date: 1987-04 Impact factor: 25.083

10. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.

Authors: F L Weber; K M Fresard; B R Lally
Journal: Gastroenterology Date: 1982-02 Impact factor: 22.682

6 in total

1. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

Authors: M Plauth; A E Roske; P Romaniuk; E Roth; R Ziebig; H Lochs
Journal: Gut Date: 2000-06 Impact factor: 23.059

2. Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.

Authors: Manuel Romero-Gomez; Maria Jover; Daniel Diaz-Gomez; Laura-Collantes de Teran; Regina Rodrigo; Ines Camacho; Miriam Echevarria; Vicente Felipo; Juan-D Bautista
Journal: World J Gastroenterol Date: 2006-04-21 Impact factor: 5.742

Review 3. Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.

Authors: Michel Tchan
Journal: Rev Endocr Metab Disord Date: 2018-03 Impact factor: 6.514